OAKWORTH CAPITAL, INC.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1588871 BIRMINGHAM, AL

Position in REGN

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$34,917

-$8,350 QoQ

Shares Held

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#1,149

of 1,322 holders

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

OAKWORTH CAPITAL, INC. holds $698,841 across 8 Biotechnology names. REGN ranks #5 (5.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	9,175	$499,211
2	VRTX	Vertex Pharmaceuticals Inc / Ma	124	$61,594
3	CRSP	CRISPR Therapeutics AG	646	$35,232
4	MRNA	Moderna, Inc.	500	$35,015
5	REGN	Regeneron Pharmaceuticals, Inc. This page	56	$34,917
6	TGTX	Tg Therapeutics, Inc.	500	$27,470
7	TECH	BIO-TECHNE Corp	74	$5,228
8	FTRE	Fortrea Holdings Inc.	10	$174

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$34,917	56	0.0%	Shares	Sole	2026-07-22
2026-03-31	$43,267	56	0.0%	Shares	Sole	2026-04-24
2025-12-31	$43,223	56	+124.0%	Shares	Sole	2026-01-30
2025-09-30	$14,056	25	+31.6%	Shares	Sole	2025-11-04
2023-09-30	$15,636	19	0.0%	Shares	Sole	2023-10-31
2023-06-30	$13,652	19	-97.3%	Shares	Sole	2023-07-28
2022-09-30	$487,031	707	0.0%	Shares	Sole	2022-10-31
2022-06-30	$417,928	707	0.0%	Shares	Sole	2022-08-05
2022-03-31	$493,782	707	-9.6%	Shares	Sole	2022-04-11
2021-12-31	$493,848	782	+73.4%	Shares	Sole	2022-02-07
2021-09-30	$272,936	451	+430.6%	Shares	Sole	2021-11-10
2021-06-30	$47,475	85	0.0%	Shares	Sole	2021-07-20
2021-03-31	$40,216	85	—	Shares	Sole	2021-04-30
No filing history on record for this holder in this stock.